Orbimed Advisors LLC Mirum Pharmaceuticals, Inc. Transaction History

Orbimed Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $4.84 Million - $7.14 Million	242,391 Added 86.72%	521,891 $11 Million
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $4.65 Million - $6.94 Million	252,500 Added 935.19%	279,500 $5.44 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.93 $418,500 - $646,110	27,000 New	27,000 $595,000
Q1 2020 May 15, 2020	SELL	$9.38 - $23.79 $668,794 - $1.7 Million	-71,300 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.84 - $25.9 $487,692 - $1.85 Million	71,300 New	71,300 $1.75 Million

190

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.61B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.